These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34846180)

  • 1. Navigated micropulse laser for central serous chorioretinopathy: Efficacy, safety, and predictive factors of treatment response.
    Amoroso F; Pedinielli A; Cohen SY; Jung C; Chhablani J; Astroz P; Colantuono D; Semoun O; Capuano V; Souied EH; Miere A
    Eur J Ophthalmol; 2022 Sep; 32(5):2810-2818. PubMed ID: 34846180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol.
    Breukink MB; Mohr JK; Ossewaarde-van Norel A; den Hollander AI; Keunen JE; Hoyng CB; Boon CJ
    Acta Ophthalmol; 2016 Mar; 94(2):187-97. PubMed ID: 26670630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy: results of the Pan-American Collaborative Retina Study (PACORES) Group.
    Roca JA; Wu L; Fromow-Guerra J; Rodríguez FJ; Berrocal MH; Rojas S; Lima LH; Gallego-Pinazo R; Chhablani J; Arevalo JF; Lozano-Rechy D; Serrano M
    Br J Ophthalmol; 2018 Dec; 102(12):1696-1700. PubMed ID: 29439089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RESPONSE OF CHOROIDAL ABNORMALITIES TO PHOTODYNAMIC THERAPY VERSUS MICROPULSE LASER IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: Place Trial Report No. 4.
    van Rijssen TJ; Hahn LC; van Dijk EHC; Tsonaka R; Scholz P; Breukink MB; Blanco-Garavito R; Souied EH; Keunen JEE; MacLaren RE; Querques G; Fauser S; Downes SM; Hoyng CB; Boon CJF
    Retina; 2021 Oct; 41(10):2122-2131. PubMed ID: 34543244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
    Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
    BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Navigated laser photocoagulation in patients with non-resolving and chronic central serous chorioretinopathy.
    Müller B; Tatsios J; Klonner J; Pilger D; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1581-1588. PubMed ID: 29876733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser.
    Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Grzybowski A
    Graefes Arch Clin Exp Ophthalmol; 2017 Dec; 255(12):2299-2306. PubMed ID: 28831603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy.
    Kim JY; Park HS; Kim SY
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2129-35. PubMed ID: 25717024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Half-fluence photodynamic therapy in chronic central serous chorioretinopathy.
    Smretschnig E; Ansari-Shahrezaei S; Hagen S; Glittenberg C; Krebs I; Binder S
    Retina; 2013 Feb; 33(2):316-23. PubMed ID: 23314238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study.
    Silva RM; Ruiz-Moreno JM; Gomez-Ulla F; Montero JA; Gregório T; Cachulo ML; Pires IA; Cunha-Vaz JG; Murta JN
    Retina; 2013 Feb; 33(2):309-15. PubMed ID: 23095766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COMPARISON OF PHOTODYNAMIC THERAPY USING HALF-DOSE OF VERTEPORFIN OR HALF-FLUENCE OF LASER LIGHT FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Cheng CK; Chang CK; Peng CH
    Retina; 2017 Feb; 37(2):325-333. PubMed ID: 27429374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Navigated laser (navilas) therapy for choroidal neovascular and hyperpermeability pathologies.
    Alshahrani ST; Ghazi NG
    Retin Cases Brief Rep; 2015; 9(2):117-20. PubMed ID: 25383841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome.
    Yadav NK; Jayadev C; Mohan A; Vijayan P; Battu R; Dabir S; Shetty B; Shetty R;
    Eye (Lond); 2015 Feb; 29(2):258-64; quiz 265. PubMed ID: 25613846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INSTRUMENTAL DIFFERENCE IN ASSESSING CHOROIDAL HYPERPERMEABILITY AND PHOTODYNAMIC THERAPY IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Lee SM; Kwon HJ; Park SW; Lee JE; Byon IS
    Retina; 2019 Jul; 39(7):1361-1369. PubMed ID: 29554076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Half-fluence photodynamic therapy in acute central serous chorioretinopathy.
    Smretschnig E; Ansari-Shahrezaei S; Moussa S; Glittenberg C; Krebs I; Binder S
    Retina; 2012; 32(10):2014-9. PubMed ID: 22466482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy.
    Zeng M; Chen X; Song Y; Cai C
    BMC Ophthalmol; 2022 Mar; 22(1):110. PubMed ID: 35260118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the efficacy of half-dose photodynamic therapy with indocyanine green angiography and optical coherence tomography findings in the treatment of central serous chorioretinopathy.
    Nicolò M; Zoli D; Musolino M; Traverso CE
    Am J Ophthalmol; 2012 Mar; 153(3):474-480.e1. PubMed ID: 22019224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term comparison between navigated subthreshold microsecond pulse laser and oral eplerenone for chronic central serous chorioretinopathy.
    Toto L; D'Aloisio R; De Nicola C; Evangelista F; Ruggeri ML; Cerino L; Simonelli MB; Aharrh-Gnama A; Di Nicola M; Porreca A; Mastropasqua R
    Sci Rep; 2022 Mar; 12(1):4727. PubMed ID: 35304566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of nondamaging subthreshold laser therapy in patients with chronic central serous chorioretinopathy.
    Lee SH; Lee J; Kim M; Roh YJ
    Graefes Arch Clin Exp Ophthalmol; 2024 May; 262(5):1433-1442. PubMed ID: 38010518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological and anatomical outcomes of subthreshold micropulse laser therapy in chronic central serous chorioretinopathy.
    Kayhan B; Demir N; Sevincli S; Sonmez M
    Photodiagnosis Photodyn Ther; 2023 Mar; 41():103221. PubMed ID: 36464217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.